Status:
RECRUITING
Prevention Strategy for Respiratory Syncytial Virus (RSV) Infections in Infants in France
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
RSV Infection
Eligibility:
FEMALE
18+ years
Brief Summary
Bronchiolitis is a viral lower respiratory tract infection, caused in 50 to 80% of cases by the respiratory syncytial virus (RSV). Although generally mild, RSV bronchiolitis remains the leading cause...
Eligibility Criteria
Inclusion
- Age ≥ 18
- Able to speak and understand French well enough to read and comprehend the information leaflet and the questionnaire
- Delivery in metropolitan France between October 1, 2024, and January 31, 2025
- Live-born child
- Term-born child (37 weeks of gestation or more)
- No objection to participating in the study
Exclusion
- Women under legal protection
Key Trial Info
Start Date :
June 17 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 17 2025
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06881953
Start Date
June 17 2025
End Date
December 17 2025
Last Update
June 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Public health department, Hôpital Pitié Salpêtrière
Paris, France, 75013